Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
International Clinical Psychopharmacology|August 5, 1998
Review of current treatment in panic disorderJ A den Boer, B R SlaapDepression and Anxiety|October 23, 2001
The prediction of nonresponse to pharmacotherapy in panic disorder: a reviewB R Slaap, J A den BoerJournal of Affective Disorders|June 20, 1996
Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of responseB R Slaap, I M van Vliet, H G Westenberg, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1996
Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorderI M van Vliet, B R Slaap, H G Westenberg, et al.Psychopharmacology|August 1, 1996
Pentagastrin has panic-inducing properties in obsessive compulsive disorderA S de Leeuw, J A Den Boer, B R Slaap, et al.Psychopharmacology|October 1, 1996
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary reportB R Slaap, I M van Vliet, H G Westenberg, et al.Journal of Clinical Psychopharmacology|August 1, 1996
A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorderI M van Vliet, J A den Boer, H G Westenberg, et al.Journal of Affective Disorders|January 11, 1995
Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report)B R Slaap, I M van Vliet, H G Westenberg, et al.Acta Neuropsychiatrica|March 12, 2016
The prediction of response in the anxiety disordersB R Slaap, I M van Vliet, H G Westenberg, et al.International Clinical Psychopharmacology|November 20, 2001
The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in periodM L Boshuisen, B R Slaap, E D Vester-Blokland, et al.Pageof 2